Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 473 of 1,261
  1. EP 3539539

    TABLETTENFORMULIERUNGEN AUS (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION

    CELGENE CORP [US] · Granted Sep 18, 2019 · Expires Sep 13, 2039

    granted
  2. US 10414656

    Discrete carbon nanotubes with targeted oxidation levels and formulations thereof

    MOLECULAR REBAR DESIGN, LLC · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  3. US 10415044

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  4. US 10415015

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  5. US 10414655

    Stem cell, bone, tissue and nerve scaffolding from discrete carbon nanotubes

    MOLECULAR REBAR DESIGN, LLC · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  6. US 10415881

    Method and device for freeze-drying drug liposomes powder assisted by variable-frequency alternating-current electric field

    South China University of Technology · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  7. US 10413548

    Methods and compositions for the inhibition of Pin1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  8. US 10413540

    Glucocorticoid receptor modulators to treat cervical cancer

    Corcept Therapeutics Incorporated · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  9. US 10413616

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  10. US 10413602

    Fungal immunogens and related materials and methods

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  11. US 10413527

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  12. US 10413577

    Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

    The Regents of the University of California · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  13. US 10413565

    Nanostructures for modulating intercellular communication and uses thereof

    Northwestern University · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  14. US 10413541

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

    Lixte Biotechnology, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  15. US 10416163

    Method and treatment of recurring endometrial cancer with an inhibitor of USP14

    Regents of the University of Minnesota · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  16. US 10413566

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Covidien LP · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  17. US 10416174

    Diagnosis and prognosis for chronic fatigue syndrome

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  18. US 10415061

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  19. US 10415040

    Nucleic acid amphiphiles and nanostructures

    Regents of the University of Minnesota · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  20. US 10415038

    Compounds and methods for modulating TMPRSS6 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  21. US 10414771

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Alliance Discovery, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  22. US 10415037

    Compositions and methods for silencing hepatitis B virus gene expression

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  23. US 10414758

    Compounds and method for treating autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  24. US 10414753

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.